能看YouTube浏览器
Corporate Profile
能看YouTube浏览器
Corporate Profile
能看YouTube浏览器
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. Sage’s lead product is approved by the U.S. Food and Drug Administration (FDA) for postpartum depression. Sage is developing a portfolio of novel product candidates targeting critical CNS receptor systems, including SAGE-217, which is in Phase 3 development in major depressive disorder and postpartum depression.
Investor Inquiries: ir@sagerx.com
Media Inquiries: ytb官网下载
Media Inquiries: ytb官网下载
能看YouTube浏览器
Day High:
Day Low:
Volume:
Day Low:
Volume:
12:57 AM EDT on
Aug 4, 2023
Aug 4, 2023
Copyright Nasdaq. Minimum 15 minutes delayed.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
- Intra
- 熊猫加速器安卓官网
- 6 mo.
- ytb官网下载
View all press releases
View all events & presentations